Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: An Italian multicenter experience

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 2, 2014, Pages 272-278

  Faraci, Maura ^a   Zecca, Marco ^b   Pillon, Marta ^c   Rovelli, Attilio ^d   Menconi, Maria Cristina ^e   Ripaldi, Mimmo ^f   Fagioli, Franca ^g   Rabusin, Marco ^h   Ziino, Ottavio ⁱ   Lanino, Edoardo ^a   Locatelli, Franco ^j   Daikeler, Thomas ^k   Prete, Arcangelo ^l  

^a G GASLINI INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f Pausilipon Hospital   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

ⁱ Ospedale dei Bambini G Di Cristina   (Italy)

^j UNIVERSITY OF PAVIA   (Italy)

^k UNIVERSITY HOSPITAL BASEL   (Switzerland)

^l UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Autoimmune hematological disease; Children; Hematopoietic stem cell transplantation; Rituximab

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; CHILD; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRESCHOOL CHILD; PURE RED CELL ANEMIA; REMISSION; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE;

AUTOIMMUNE HEMATOLOGICAL DISEASE; CHILDREN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; RITUXIMAB;

CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ITALY; MALE; REMISSION INDUCTION; RISK FACTORS; TRANSPLANTATION CONDITIONING;

EID: 84893058418     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.11.014     Document Type: Article

References (36)

1. Tivol E., Komorowski R., Drobyski W.R. Emergent autoimmunity in graft-versus-host disease. Blood 2005, 105:4885-4891.
2. Drobyski W.R., Potluri J., Sauer D., et al. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996, 17:1093-1099.
3. O'Brien T.A., Eastlund T., Peters C., et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004, 127:67-75.
4. Loh Y., Oyama Y., Statkute L., et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood 2007, 109:2643-2648.
5. Daikeler T., Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007, 20:349-360.
6. Daikeler T., Labopin M., Ruggeri A., et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of EBMT. Blood 2013, 121:1059-1064.
7. Page K.M., Mendizabal A.M., Prasad V.K., et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008, 14:1108-1117.
8. Klein J.P., Rizzo J.D., Zhang M.J., et al. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I. Unadjusted analysis. Bone Marrow Transplant 2001, 28:909-915.
9. Pepe M.S., Longton G., Pettinger M., et al. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 1993, 83:602-607.
10. Gray R.J. Aclass of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
11. Fine J.P., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. JAm Stat Assoc 1999, 94:496-509.
12. Scrucca L., Santucci A., Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007, 40:381-387.
13. Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
14. Sanz J., Arriaga F., Montesinos P., et al. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007, 39:555-561.
15. Chen F.E., Owen I., Savage D., et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997, 19:491-495.
16. Urban C., Benesch M., Sovinz P., et al. Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome. Eur J Haematol 2004, 72:444-447.
17. Beck J.C., Burke M.J., Tolar J. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim. Pediatr Blood Cancer 2010, 54:490-491.
18. Daikeler T., Labopin M., Di Gioia M., et al. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood 2011, 118:1693-1698.
19. Sherer Y., Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998, 22:873-881.
20. Hartert A., Willenbacher W., Günzelmann S., et al. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT. Bone Marrow Transplant 2001, 27:337-340.
21. Holbro A., Abinun M., Daikeler T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol 2012, 157:281-290.
22. Hongeng S., Tardtong P., Worapongpaiboon S., et al. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant 2002, 29:871-872.
23. Simms-Waldrip T., Ikeda A., Goldfinger D., et al. Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010, 45:201-202.
24. Raj K., Narayanan S., Augustson B., et al. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Bone Marrow Transplant 2005, 35:299-301.
25. Lee S.J., Churchill W.H., Konugres A., et al. Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation-treatment with anti-D immunoglobulin. Bone Marrow Transplant 1997, 19:173-174.
26. Dovat S., Roberts R.L., Wakim M., et al. Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine. Bone Marrow Transplant 1999, 24:321-323.
27. Proleznik I., Prentice H.G., Pretnar J., et al. Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report. Int J Hematol 2005, 82:75-78.
28. Quartier P., Brethon B., Philippet P., et al. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001, 358:1511-1513.
29. Zecca M., Nobili B., Ramenghi U., et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003, 101:3857-3861.
30. Delgado J., Bustos J.G., Jimenez-Yuste V., et al. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura. Haematologica 2002, 87:215-216.
31. Zecca M., De Stefano P., Nobili B., et al. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood 2001, 97:3995-3997.
32. Heyll A., Aul C., Runde V., et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991, 77:906.
33. Santamaría A., Sureda A., Martino R., et al. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 1997, 20:1105-1107.
34. Poon L.M., Koh L.P. Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib. Bone Marrow Transplant 2012, 47:870-871.
35. Tosi P., Bandini G., Tazzari P., et al. Autoimmune neutropenia after unrelated bone marrow transplantation. Bone Marrow Transplant 1994, 14:1003-1004.
36. Klumpp T.R., Block C.C., Caligiuri M.A., et al. Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature. Medicine (Baltimore) 1992, 71:73-83.